화학공학소재연구정보센터
Macromolecular Research, Vol.17, No.2, 72-78, February, 2009
Formation of Poly(ethylene glycol)-Poly(ε-caprolactone) Nanoparticles via Nanoprecipitation
E-mail:
Size control of therapeutic carriers in drug delivery systems has become important due to its relevance to biodistribution in the human body and therapeutic efficacy. To understand the dependence of particle size on the formation condition during nanoprecipitation method, we prepared nanoparticles from biodegradable, amphiphilic block copolymers and investigated the particle size and structure of the resultant nanoparticles according to various process parameters. We synthesized monomethoxy poly(ethylene glycol)-poly(ε-caprolactone) block copolymer, MPEG-PCL, with different MPEG/PCL ratios via ring opening polymerization initiated from the hydroxyl end group of MPEG. Using various formulations with systematic change of the block ratio of MPEG and PCL, solvent choice, and concentration of organic phase, MPEG-PCL nanoparticles were prepared through nanoprecipitation technique. The results indicated that (i) the nanoparticles have a dual structure with an MPEG shell and a PCL core, originating from self-assembly of MPEG-PCL copolymer in aqueous condition, and (ii) the size of nanoparticles is dependent upon two sequential processes: diffusion between the organic and aqueous phases and solidification of the polymer.
  1. Pihlajamaki H, Bostman O, Tynninen O, Laitinen O, Bone, 39, 932 (2006)
  2. Laitinen O, Pihlajamaki H, Sukura A, Bostman O, J. Biomed. Mater. Res., 61, 33 (2002)
  3. Huang Q, Hutmacher DW, Lee EH, Tissue Eng., 8, 469 (2002)
  4. Edwards RC, Kiely KD, Eppley BL, J. Oral Maxil. Surg., 59, 19 (2001)
  5. Yoshimoto H, Shin YM, Terai H, Vacanti JP, Biomaterials, 24, 2077 (2003)
  6. Zhang YZ, Huang ZM, Xu XJ, Lim CT, Ramakrishna S, Chem. Mater., 16, 3406 (2004)
  7. Chen VJ, Smith LA, Ma PX, Biomaterials, 27, 3973 (2006)
  8. Ouyang HW, Toh SL, Goh J, Tay TE, Moe K, J. Biomed. Mater. Res. B, 75B, 264 (2005)
  9. Li WJ, Laurencin CT, Caterson EJ, Tuan RS, Ko FT, J. Biomed. Mater. Res., 60, 613 (2002)
  10. Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M, J. Control. Release, 89, 341 (2003)
  11. Lee CT, Huang CP, Lee YD, Biomacromolecules, 7(7), 2200 (2006)
  12. Liggins RT, Burt HM, Int. J. Pharm., 222, 19 (2001)
  13. Hu FX, Neoh KG, Kang ET, Biomaterials, 27, 5725 (2006)
  14. Lee HY, Yu SA, Jeong KH, Kim YJ, Macromol. Res., 15(6), 547 (2007)
  15. Govender T, Stolnik S, Garnett MC, Illum L, Davis SS, J. Control. Release, 57, 171 (1999)
  16. Zhang H, Gao S, Int. J. Pharm., 329, 122 (2007)
  17. Xiong XB, Mahmud A, Uludag H, Lavasanifar A, Biomacromolecules, 8(3), 874 (2007)
  18. Allen C, Yu YS, Maysinger D, Eisenberg A, Bioconjugate Chem., 9, 564 (1998)
  19. Zhu GZ, Mallery SR, Schwendeman SP, Nat. Biotechnol., 18, 52 (2000)
  20. Lee M, Chen TT, Iruela-Arispe ML, Wu BM, Dunn JCY, Biomaterials, 28, 1862 (2007)
  21. Walter E, Moelling K, Pavlovic J, Merkle HP, J. Control. Release, 61, 361 (1999)
  22. Cohen H, Levy RJ, Gao J, Fishbein I, Kousaev V, Sosnowski S, Slomkowski S, Golomb G, Gene Ther., 7, 1896 (2000)
  23. Yuan XD, Li L, Rathinavelu A, Hao JS, Narasimhan M, He M, Heitlage V, Tam L, Viqar S, Salehi M, J. Nanosci. Nanotechno., 6, 2821 (2006)
  24. You JH, Choi SW, Kim JH, Kwak YT, Macromol. Res., 16(7), 609 (2008)
  25. Bhattarai SR, Bhattarai N, Yi HK, Hwang PH, Cha DI, Kim HY, Biomaterials, 25, 2595 (2004)
  26. Im SJ, Choi YM, Subramanyam E, Huh KM, Park K, Macromol. Res., 15(4), 363 (2007)
  27. Choi C, Jang MK, Nah JW, Macromol. Res., 15(7), 623 (2007)
  28. Deng C, Tian HY, Zhang PB, Sun J, Chen XS, Jing XB, Biomacromolecules, 7(2), 590 (2006)
  29. Park C, Rhue M, Lim J, Kim C, Macromol. Res., 15(1), 39 (2007)
  30. Lee SC, Kim C, Kwon IC, Chung H, Jeong SY, J. Control. Release, 89, 437 (2003)
  31. Ping P, Wang WS, Chen XS, Jing XB, Biomacromolecules, 6(2), 587 (2005)
  32. Lee JS, Kim SH, Kim YJ, Akaike T, Kim SC, Biomacromolecules, 6(4), 1906 (2005)
  33. Ma ZW, Gao CY, Gong YH, Shen JC, Biomaterials, 26, 1253 (2005)
  34. Barbault-Foucher S, Gref R, Russo P, Guechot J, Bochot A, J. Control. Release, 83, 365 (2002)
  35. Oh SH, Kang SG, Kim ES, Cho SH, Lee JH, Biomaterials, 24, 4011 (2003)
  36. Mi FL, Lin YM, Wu YB, Shyu SS, Tsai YH, Biomaterials, 23, 3257 (2002)
  37. Kim SY, Cho SH, Lee YM, Chu LY, Macromol. Res., 15(7), 646 (2007)
  38. Leroux JC, Allemann E, DeJaeghere F, Doelker E, Gurny R, J. Control. Release, 39, 339 (1996)
  39. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R, Science, 263(5153), 1600 (1994)
  40. Juliano RL, Adv. Drug Deliver. Rev., 2, 31 (1988)
  41. Torchilin VP, Trubetskoy VS, Adv. Drug Deliver. Rev., 16, 141 (1995)
  42. Moghimi SM, Hunter AC, Murray JC, Pharmacol. Rev., 53, 283 (2001)
  43. Storm G, Belliot SO, Daemen T, Lasic DD, Adv. Drug Deliver. Rev., 17, 31 (1995)
  44. Gatmaitan Z, Varticovski L, Ling L, Mikkelsen R, Steffan AM, Arias IM, Am. J. Pathol., 148, 2027 (1996)
  45. Song CX, Labhasetwar V, Murphy H, Qu X, Humphrey WR, Shebuski RJ, Levy RJ, J. Control. Release, 43, 197 (1997)
  46. Lu W, Zhang Y, Tan YZ, Hu KL, Jiang XG, Fu SK, J. Control. Release, 107, 428 (2005)
  47. Shim WS, Lee JS, Lee DS, Macromol. Res., 13(4), 344 (2005)
  48. Dong YC, Feng SS, Biomaterials, 25, 2843 (2004)
  49. Galindo-Rodriguez S, Allemann E, Fessi H, Doelker E, Pharm. Res., 21, 1428 (2004)
  50. Cheng J, Teply BA, Sherifi I, Sung J, Luther G, Gu FX, Levy-Nissenbaum E, Radovic-Moreno AF, Langer R, Farokhzad OC, Biomaterials, 28, 869 (2007)
  51. Hoy KL, The Hoy: Tables of Solubility Parameters, Union Carbide Corporation, South Charleston, 1985
  52. Hansen CM, Hansen Solubility Parameters: A User's Handbook, CRC Press, Boca Raton, 2000